We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Published results showed patients with shoulder ...

POSIMIR ® (bupivacaine solution) for infiltration use reduced mean pain over 72 hours after arthroscopic subacromial decompression surgery compared with vehicle control and improved several measures ...

Please provide your email address to receive an email when new articles are posted on . Durect Corporation has announced the FDA approval of Posimir, a post-surgical, non-opioid local analgesic for ...

The revision of CPT 29826 from a standalone code to an add-on code — +29826 (Arthroscopy, shoulder, surgical; decompression of subacromial space with partial acromioplasty, with coracoacromial ...

Arthroscopic subacromial decompression surgery does not reduce pain any more than arthroscopy alone in people with shoulder impingement, researchers say. "[T]he findings from our study suggest that ...

Common surgery given to thousands of patients battling shoulder pain doesn't work, according to mounting evidence. Decompression surgery is used to manage the symptoms of the most common form of ...

A new study claims patients undergoing one of the most common surgical procedures in the western world might be wasting their time. A team of researchers from the University of Helsinki has spent the ...

CUPERTINO, Calif., Feb. 2, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has approved POSIMIR® (bupivacaine solution) for ...

Tim Jones receives funding from the National Institute for Health Research (NIHR), Department of Health and Social Care, UK. The views expressed in this article are those of the author(s) and not ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...